One of the greatest fears of a life sciences company is the possibility of being sued for intellectual property violation shortly before their IPO. Such a lawsuit can destabilize market confidence in the company, raise questions on whether or not the product will ever come to market, or it can halt the IPO. Attorneys Cyrus Morton and Jake Holdreith explain what life science companies can do to mitigate and avoid these aforementioned risks.